A meta‐analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease

Hernán, Miguel A., Takkouche, Bahi, Caamaño‐Isorna, Francisco, Gestal‐Otero, Juan J.·2002·Annals of Neurology
DOI 10.1002/ana.10277

Cited by (817)

Items 601–700 of 817

  1. Coffee and Health
    Gary Williamson · 2011 · Wiley eBooks
  2. Smoking, Parkinson's Disease, and Melanoma
    William Burgess Grant · 2007 · Cancer Epidemiology Biomarkers & Prevention
  3. Risk Factors for the Diagnosis of Progressive Supranuclear Palsy in the UK Biobank
    Charlie Weige Zhao, Marian L. Dale, Alexander Y. Pantelyat, Maria Carmela Tartaglia, Ruth B. Schneider, David G. Coughlin, Federico E Rodriguez‐Porcel, Zbigniew K. Wszołek, Tao Xie, Lawrence I. Golbe et al. · 2026 · Movement Disorders
  4. Parkinson’s Disease: Contemporary Concepts and Clinical Management
    Vanessa Carvalho, Carlota Vicente Cunha, João Massano · 2018 · Springer eBooks
  5. Influence of Cigarette Aerosol in Alpha-Synuclein Oligomerization and Cell Viability in SH-SY5Y: Implications for Parkinson’s Disease
    Yuxin Shen, Pe-Shuen Lee, Ming-Chu Teng, Jhih-Hong Huang, Chia C. Wang, Hsiu‐Fang Fan · 2024 · ACS Chemical Neuroscience
  6. α7‐Nicotinic Acetylcholine Receptor and Mutated α‐Synuclein Interact in Motor Behaviour and Nigrostriatal Dopamine—Findings With Potential Relevance for a Protective Effect of Cigarette Smoking and Parkinson's Disease
    Christian Pifl, Alexandra Wolf, Mark Elevado, Petra Scholze · 2025 · European Journal of Neuroscience
  7. Insights on the Association between Antimicrobial Use and Risk of Parkinson’s Disease: A Systematic Review and Meta-Analysis
    Moaz Elsayed Abouelmagd, Omar Kassar, Atef Hassan, Maickel AbdelMeseh, Abdelrahman Mady, Hamdy A. Makhlouf · 2025 · Neuroepidemiology
  8. Symposium on Plant Polyphenols: Nutrition, Health and Innovations, June 2009
    Ann S. Chang, Boon-Yee Yeong, Woon‐Puay Koh · 2010 · Nutrition Reviews
  9. Smoking cessation for the neurologic patient
    Jinny O. Tavee · 2012 · Neurology Clinical Practice
  10. Enhanced serum myeloperoxidase level correlates with clinical features of Parkinson's disease
    Emilio Fernández‐Espejo · 2022 · ANALES RANM
  11. Salivary ATP13A2 is a potential marker of therapy-induced motor complications and is expressed by inclusions in submandibulary glands in Parkinson s disease
    Emilio Fernández‐Espejo, Ana Gavito, Juan Suárez, EDUARDO S. TOLOSA, Dolores Vilas, Ibán Aldecoa, Juan Berenguer, Antonio Córdoba-Fernández, Fátima Damas-Hermoso, Fernando Rodrı́guez de Fonseca · 2022 · Clinical Parkinsonism & Related Disorders
  12. Neuroprotective strategies in Parkinson’s disease
    Divyani Garg, Soaham Desai · 2021 · Annals of Movement Disorders
  13. Gene Expression Analysis Approach to Establish Possible Links Between Parkinson's Disease, Cancer and Cardiovascular Diseases
    Sajjad Karim, Zeenat Mirza, Mohammad Amjad Kamal, Adel Mohammed Abuzenadah, Mohammed H Al-Qahtani · 2014 · CNS & Neurological Disorders - Drug Targets
  14. Movement Disorders
    Joseph J. Jankovic · 2007 · Elsevier eBooks
  15. Should we irradiate a brain tumor in a patient with parkinsonism? A case report and literature review
    Alexander Engelman, Karthikeyan Perumal, Minesh P. Mehta · 2015 · Practical Radiation Oncology
  16. Premorbid Personality Traits and Brain Recovery: Another Aspect of Resilience
    Daniela Laricchiuta, Sebastian A. Markett, Martin Reuter, Christian Montag · 2017 · Contemporary clinical neuroscience
  17. Pharmacological Properties and Neurophsysiological Effects of Caffeine
    Astrid Nehlig · 2006 · CRC Press eBooks
  18. The role of caffeine consumption on individuals' health and athletic performance: An overview
    Konstantinos D. Tambalis, Giannis Arnaoutis · 2022 · International Journal of Physiology Nutrition and Physical Education
  19. Zebrafish as a model of Parkinson's disease
    Ville J. Sallinen · 2009 · Työväentutkimus Vuosikirja
  20. Restoration of MPTP-induced Dopamine and Tyrosine Hydroxylase Depletion in the Mouse Brain Through Ethanol and Nicotine
    Mostofa Jamal, Sella Takei, Ikuko Tsukamoto, Takanori Miki, Ken‐ichi Ohta, Md Zakir Hossain, Hiroshi Kinoshita · 2025 · Neurotoxicity Research
  21. Association of a Healthy Lifestyle with Risk of Parkinson’s Disease and Genetic Predisposition
    Qirui Jiang, Junyu Lin, Qianqian Wei, Chunyu Li, Ruwei Ou, Lingyu Zhang, Yanbing Hou, Tianmi Yang, Yi Xiao, Shichan Wang et al. · 2025 · Neuroepidemiology
  22. Neuroprotective effects of chemical constituents from Nicotiana tabacum L. in Parkinson’s disease
    Hao‐Jing Zang, Xiaolin Bai, Xueyi Sui, Xiao-Rui Zhai, Yongcui Wang, Qiuyuan Yin, Qiu-Yuan Yin, Xiao‐Jiang Hao, Yue-Hu Wang, Xun Liao et al. · 2025 · Natural Products and Bioprospecting
  23. Smoking, Exhaled Carbon Monoxide, and Risk of Parkinson Disease
    Clara Bueno López, Andri Iona, Iain James Turnbull, Huaidong Du, Yiping Chen, Ling Yang, Alexander Clive Tinworth, Zhengjie Shen, Kshitij Kolhe, Pei Pei et al. · 2026 · JAMA Neurology
  24. Chronic Inflammation Connects the Development of Parkinson’s Disease and Cancer
    Zhiming Li, Chi‐Meng Tzeng · 2016 · InTech eBooks
  25. The Effect of Caffeine on Health and Exercise Performance with a Cold Brew Coffee Approach: A Scoping Review
    Hoseyn Fatolahi, A.H. Taghizad Farahmand, Shabnam Rezakhani · 2020 · Nutrition and Food Sciences Research
  26. Parkinson’s disease case ascertainment in a large prospective cohort
    Srishti Shrestha, Christine Gibson Parks, Marie Richards-Barber, Honglei Chen, Dale P. Sandler · 2021 · PLoS ONE
  27. Parkinson’s Disease: A Comprehensive Overview of the Disease
    Ahed J Al Khatib · 2023 · IntechOpen eBooks
  28. Comparative study of bilateral putamen for patients with severe Parkinson’s disease detected by 1H magnetic resonance spectroscopy
    Biao Qu, Xiaoyuan Li, Min Xiao, Runhan Chen, Hejuan Tan, Hongwei Sun, Rushuai Li, Jingjing Xu, Jiyang Dong, Gaofeng Zheng et al. · 2023 · Quantitative Imaging in Medicine and Surgery
  29. Prevalence and Distribution of Lewy Pathology in a Homeless Population
    Krisztina Danics, Naomi P. Visanji, Shojiro Ichimata, Sarika Mathur, Gabriella Sára-Klausz, Gábor Géza Kovács · 2023 · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
  30. Exploring the Nicotine-Parkinson's disease link – Insights from the UK Biobank
    Sarah Bouhadoun, Sheida Zolfaghari, Aline Delva, Amélie Pelletier, Trycia Kouchache, Alain Dagher, Filip Morys, Andrew Vo, Mirja Kuhlencord, Ronald B. Postuma · 2024 · Parkinsonism & Related Disorders
  31. The effect of a nicotine-rich diet with/without redistribution of dietary protein on motor indices in patients with Parkinson’s disease: A randomized clinical trial
    Hamid Lorvand Amiri, Mohammad Hassan Javanbakht, Seyed Mohammad Baghbanian, Mahboubeh Parsaeian · 2024 · Journal of Clinical Neuroscience
  32. Association between wide-ranging food intake and Parkinson’s disease: a comprehensive mendelian randomization study
    Yana Su, Yulei Hao, Wanhui Dong, Ruqing Qiu, Ying Zhang · 2025 · Scientific Reports
  33. Intestinal dysbiosis leads to the reduction in neurochemical production in Parkinson’s disease (PD)
    Rahul Kumar, Rahul Kumar · 2025 · International review of neurobiology
  34. Clinical and Genetic Characteristics of Parkinson’s Disease Patients with Substantia Nigra Hyperechogenicity
    Łukasz Milanowski, Piotr Szukało, Małgorzata Kowalska, Alicja Sikorska, Dorota Hoffman‐Zacharska, Dariusz Koziorowski · 2025 · International Journal of Molecular Sciences
  35. Factores asociados a la enfermedad de Parkinson en pacientes de la Comarca Lagunera, México
    Raymundo Ventura-Chávez, Ana I. Reyna-Gil, Silvia Garcı́a · 2019 · Revista de Fomento Social
  36. Uso medicinal da Cannabis sativa no tratamento da Doença de Parkinson
    Julia Stanziola Ferreira, Sara Eckert, Rômulo Lourenço Séleri, Marina Stanziola Ferreira · 2023 · Brazilian Journal of Health Review
  37. Unexpected benefits of allergies and cigarette smoking: two examples of paradox in neuroepidemiology
    Judith Schwartzbaum, Linda M. Karavodin, Narinder Kapur, James L. Fisher · 2011 · Cambridge University Press eBooks
  38. Caffeine and Neuroprotection in Parkinson’s Disease
    Filipe Brogueira Rodrigues, Daniel Caldeira, Joaquim José Ferreira, João Guilherme Costa · 2015 · Current topics in neurotoxicity
  39. Epidemiology
    Raymond Y. Lo, Caroline M. Tanner · 2013 · Informa Healthcare eBooks
  40. The Promise of Mendelian Randomization in Parkinson’s Disease: Has the Smoke Cleared Yet for Smoking and Parkinson’s Disease Risk?
    Beate R. Ritz, Cynthia Kusters · 2022 · Journal of Parkinson s Disease
  41. Coffee, Granulocyte Colony-Stimulating Factor (G-CSF), and Neurodegenerative Diseases
    Chuanhai Cao, Thea R. Moore, Li Chu, Qing Xu · 2014 · Coffee in Health and Disease Prevention
  42. Role of the Innate and Adaptive Immune System in the Pathogenesis of PD
    George T. Kannarkat, Malú G. Tansey · 2014 · Springer eBooks
  43. Coffee consumption and type 2 diabetes mellitus
    Lina Radzevičienė, Rytas Ostrauskas · 2009 · Medicina
  44. Nuclear translocation of the unliganded glucocorticoid receptor is influenced by membrane fluidity, but not A2AR agonism
    Daniel E. Oseid, Liqing Song, Sierra K. Lear, Anne Skaja Robinson · 2020 · Steroids
  45. Does Caffeine Consumption Affect the Symptoms of Parkinson’s Disease? A Systematic Review of Clinical Trials
    Anita Reyhanifard, Sarvin Sanaie, Mojgan Mirghafourvand‬‬‬‬‬‬‬‬‬‬‬‬‬‬, Sama Rahnemayan, Arezoo Fathalizadeh, Ata Mahmoodpoor, Elnaz Faramarzi · 2021 · Archives of Neuroscience
  46. Therapeutic and Diagnostic Agents for Parkinson's Disease
    Raymond G. Booth, John L. Neumeyer, Ross J. Baldessarini · 2010 · Burger's Medicinal Chemistry and Drug Discovery
  47. Hiding in plain sight
    Shannon S. Sullivan, Carlos Hugh Schenck, Christian Guilleminault · 2012 · Neurology
  48. Accelerating Research on Genes and Environment in Parkinson?s Disease
    J. William Langston · 2005 · Environmental Health Perspectives
  49. Coffee and Risk of Type 2 Diabetes
    Siamak Bidel, J. Tuomilehto · 2007 · Työväentutkimus Vuosikirja
  50. Association between Low Blood Pressure and Subsequent Risk of Parkinson’s Disease in Older Adults Aged ≥75 Years
    Ja Young Choi, Kyungdo Han, Yong Wook Kim, Sang Chul Lee, Jaeyong Shin, Seung Nam Yang, Seo Yeon Yoon · 2023 · Gerontology
  51. Herbal Medicine and Skeletal Muscle Atrophy: From Basic Science to Translational Medicine
    Sima Seifi, Afshin Karimi, Abdoljalal Marjani, Mina Maftooh, Elnaz Ghorbani, Hamid Fiuji, Majid Ghayour‐Mobarhan, Gordon A. Ferns, Majid Khazaei, Seyed Mahdi Hassanian Mehr et al. · 2024 · Current Traditional Medicine
  52. Transcription-Driven Repurposing of Cardiotonic Steroids for Lithium Treatment of Severe Depression
    Richard Killick, Claudie Hooper, Cathy Fernandes, Christina Elliott, Dag Aarsland, Svein Reidar Kjosavik, Ragnhild Oesterhus, Gareth Haydn Williams · 2025 · Cells
  53. Association between alcohol consumption and mortality in Parkinson’s disease
    Yu Hyun Park, Yong Wook Kim, Dae Ryong Kang, Seo Yeon Yoon · 2025 · Journal of Neural Transmission
  54. Expanding the Arsenal of Nanocarriers Against Parkinson Disease: Success so Far Roads Ahead
    Naina Devi, Sonia Dhiman, Chander Parkash Dora, Thakur Gurjeet Singh, Ankit Awasthi · 2025 · AAPS PharmSciTech
  55. The effects of nicotine on Parkinson's disease: A systematic review and meta-analysis of experimental evidence
    Gudisa Bereda, Javed Ahamad · 2026 · IBRO Neuroscience Reports
  56. Oxidative stress and inflammation in neurodegenerative disorders
    Klaudia Jomová, Suliman Yousef Alomar, Richard Valko, Eugenie Nepovimová, Kamil Kuča, Marián Valko · 2026 · Archives of Toxicology
  57. Adult-administered chronic nicotine remodels nigral dopaminergic and pedunculopontine cholinergic physiology
    Rita Yu-Tzu Chen, Hassan Hosseini, Skylar Hall, Shirley Q Zhang, Rebekah C. Evans · 2026 · Neuropharmacology
  58. Parkinson’s Disease: Insights from the Laboratory and Clinical Therapeutics
    Jing-ye Zhou, Yong Yu, Xian-Lun Zhu, Chi-Ping Ng, Gang Lü, Wai-Sang Poo · 2012 · InTech eBooks
  59. Epidemiologia descrittiva e analitica della malattia di Parkinson
    Massimo Musicco · 2009 · Springer eBooks
  60. Pesticides and Parkinson's
    Jonathan B Weitzman · 2001 · Trends in Molecular Medicine
  61. Estudio caso-control en búsqueda de una asociación entre el consumo de yerba mate y la enfermedad de Parkinson (datos preliminares)
    Carlos Mario Melcon, Leonardo C. Bartoloni, Virginia Laura Parisi, Claudio Daniel González, Nélida Garretto, Tomoko Arakaki, Hernán Pavón, José A. Bueri, Marcelo Mattiazzi, Emilia Mabel Gatto · 2014 · Neurología Argentina
  62. In search of the causes of Parkinson’s disease, seasons 1 to 4
    Alexis Elbaz · 2011 · European Journal of Epidemiology
  63. Sleep, Adenosine and Caffeine as Tools for The Early Diagnosis of Parkinson Disease
    Rafael J. Salín-Pascual · 2012 · The Open Sleep Journal
  64. Genetic and Environmental Factors in Neurodegenerative Diseases
    Fabio Coppedè, Lucia Migliore · 2007 · Elsevier eBooks
  65. Epidemiology of Parkinson's disease
    Louis C.S. Tan · 2013
  66. Licencia para fumar
    Juan F F Medrano · 2017
  67. Investigation of Inhibition Effect of Nicotine and Dopamine on Alpha-synuclein
    Hakan Alıcı · 2021 · Journal of Computational Biophysics and Chemistry
  68. Epidemiology of Parkinson’s Disease—Current Understanding of Causation and Risk Factors
    Rajan R Patil · 2021 · Series in bioengineering
  69. Does Nicotine from Passive Smoking and Foods Protect Against Parkinson’s Disease?
    Elnaz Faramarzi, Arezoo Fathalizadeh, Sarvin Sanaie, Mojgan Mirghafourvand‬‬‬‬‬‬‬‬‬‬‬‬‬‬, Anita Reyhanifard, Sama Rahnemayan, Ata Mahmoodpoor · 2022 · Current Nutrition & Food Science
  70. Medicine
    Gerd Kempermann · 2010 · Oxford University Press eBooks
  71. Épidémiologie
    Virginie Chrysostome, François Tison · 2015 · Elsevier eBooks
  72. Nicotine-Dependent Risk Of Developing Parkinson’s Disease
    Arto Zilfyan, Stepan Avagyan · 2023 · THE NEW ARMENIAN MEDICAL JOURNAL
  73. Impact of Hydrocarbon Exposure on the Risk of Parkinson's Disease
    Soraia El Baz, Rania Lotfi, Nour-Eddine Mezrioui, Abdelmohcine Aimrane, Ahmed Draoui, Bilal El‐Mansoury, Mohamed Echchakery, Ouafae El Hamiani, Hanane Moummou, Lamia Daghor · 2023 · Advances in medical diagnosis, treatment, and care (AMDTC) book series
  74. Physical activity affects DNA methylation-derived inflammation markers in a community-based Parkinson's disease study
    Yang Cheng Hu, Keren Zhang, Kimberly C. Paul, Jin Zhou, Jeff M. Bronstein, Cynthia Kusters, Beate R. Ritz · 2025 · Brain Behavior & Immunity - Health
  75. Clinical Disease Progression in Parkinson’s Disease
    Guido Werner Alves · 2006
  76. The role of beverages in a healthy diet: key issues and guidelines
    Barry M. Popkin, George M Bray, Benjamin H Caballero, Balz B. Frei, Walter Churchill Willett · 2009 · Elsevier eBooks
  77. Gut Microbiota in Brain Development and Disorders of the CNS: Therapeutic Strategies Involving Dietary Modification, Pro- and Prebiotic Intervention, and Fecal Microbiota Transplantation (FMT) Therapy
    Bryan C. Tungland · 2018 · Elsevier eBooks
  78. Effects of Caffeine and Chlorogenic Acid on Nonalcoholic Steatohepatitis in Mice Induced by Choline-Deficient, L-Amino Acid-Defined, High-Fat Diet
    Erdenetsogt Dungubat Shiori Watabe, Arisa Togashi-Kumagai, Masato Watanabe, Yasuyuki Kobayashi, Naoki Harada, Ryoichi Yamaji, Toshio Fukusato, Galtsog Lodon, Badamjav Sevjid, Yoshihisa Takahashi · 2021 · Vide Leaf, Hyderabad eBooks
  79. Cigarette Smoking, nicotine and Parkinson’s disease: Controversies in clinical trials data and medical practice.
    A.A. Kesoyan., N.L. Arakelyan, D.A. Aloyan, A.A. Karapetyan, Hovhannes M. Manvelyan · 2022 · THE NEW ARMENIAN MEDICAL JOURNAL
  80. Over-expression and biophysical characterisation of membrane proteins solubilised in a styrene maleic acid polymer
    Yu-Pin Lin · 2011 · UPT. Syiah Kuala University Library (Syiah Kuala University)
  81. Indicators of Early Adult and Current Personality in Parkinson's Disease
    Kelly L. Sullivan · 2011 · Digital Commons - University of South Florida (University of South Florida)
  82. Épidémiologie
    Virginie Chrysostome, François Tison · 2011 · Elsevier eBooks
  83. Evaluating epidemiologic associations between occupational whole body vibration and Parkinson's disease
    Margaret Harris · 2010 · cIRcle (University of British Columbia)
  84. PARKINSON'S DISEASE
    Oksana Suchowersky, Sarah Furtado · 2004 · CONTINUUM Lifelong Learning in Neurology
  85. "A GREAT PERTURBATION IN NATURE" : PARKINSON'S DISEASE AND SLEEP DISORDERS
    Ari Ylikoski · 2016 · Työväentutkimus Vuosikirja
  86. The causal direction in the association between Parkinson’s disease and cigarette or nicotine use
    Nikodem Grzesiak · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
  87. Neurologic Diseases
    Eric T. Stoopler, Michael L. McGarvey · 2021
  88. Parkinson's Disease
    Samuel M. Goldman · 2013
  89. Smoking, Parkinson's Disease, and Melanoma
    Jane Ann Driver, Giancarlo Logroscino, Julie E. Buring, J. Michael Gaziano, Tobias Kurth · 2007 · Cancer Epidemiology Biomarkers & Prevention
  90. Molecular insight into the mechanism of action of some beneficial flavonoids for the treatment of Parkinson’s Disease
    Sima Biswas, Anindita Mitra, Sreekanya Roy, Rita Ghosh, Angshuman Bagchi · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  91. Unraveling the Decline: Search for Factors Behind the Trend in Parkinson’s Disease Incidence Rates – A Cohort Study of German Health Claims Data
    Anne Fink, Maria Angeliki S. Pavlou, Kirsten Roomp, Gabriele Doblhammer, Jochen G. Schneider · 2023 · medRxiv
  92. Defining The Potential Of Gene Therapy With Bone Morphogenetic Proteins As A Novel Therapeutic Approach In Parkinson's Disease
    Susan R. Goulding · 2021
  93. Dynamic Smoking Patterns and Risk of Parkinson Disease
    Daniele Urso, Giancarlo Logroscino · 2026 · Neurology
  94. Environmental Factors and Parkinson's Disease
    Caroline M. Tanner · 2009 · Blue books of neurology
  95. Case-only study of interactions between specific genetic polymorphisms and cigarette smoking in the aetiology of Parkinson's disease
    Yifu Deng · 2005 · Centre for Health Research; Faculty of Health; Institute of Health and Biomedical Innovation
  96. Sex Differences in Cardiovascular Drug Response
    Eline M. Rodenburg · 2012 · RePub (Erasmus University Rotterdam)
  97. Caffeine Reduces Risk of Parkinson’s Disease
    Nuttiya Harnprasertpongse, Chaichan Sangdee · 2014 · Journal of Basic and Applied Pharmacology
  98. Determinants of cognitive decline in older European men
    B.M. van Gelder · 2007
  99. An Epidemiological Appraisal of Smoking‐Related Outcomes
    Elke Munters, Tim S. Nawrot · 2011 · Wiley eBooks
  100. Autosomal recessive, early-onset Parkinson’s disease
    Vincenzo Bonifati · 2003 · RePub (Erasmus University Rotterdam)